SMTL ID : 5n2r.1

Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with PSB36 at 2.8A resolution

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x NA: SODIUM ION(Non-functional Binders)

NA.1: 4 residues within 4Å: Chain A: L.57, D.61, S.100, N.385 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:D.61, A:S.100, A:N.385 Water bridges: A:D.61

1 x 8JN: 1-butyl-3-[(~{E})-3-oxidanylprop-1-enyl]-8-[(1~{R},5~{S})-3-tricyclo[3.3.1.0^{3,7}]nonanyl]-7~{H}-purine-2,6-dione(Non-covalent)

8JN.2: 17 residues within 4Å: Chain A: I.75, V.93, F.177, E.178, M.183, M.186, W.351, L.354, I.357, N.358, T.361, H.369, M.375, Y.376, I.379, A.382, H.383 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.93, A:E.178, A:W.351, A:W.351, A:L.354, A:I.357, A:T.361, A:I.379, A:A.382 Hydrogen bonds: A:N.358, A:N.358 pi-Stacking: A:F.177

3 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 9 residues within 4Å: Chain A: F.71, A.81, A.82, G.85, F.88, I.89, Q.172 Ligands: OLA.9, OLC.29 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.71, A:A.81, A:F.88, A:I.89 Hydrogen bonds: A:A.82, A:Q.172 CLR.4: 8 residues within 4Å: Chain A: L.352, P.353, I.357, F.360, C.367, S.368, L.374 Ligands: OLA.7 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.352, A:P.353, A:I.357, A:F.360 Hydrogen bonds: A:S.368 CLR.5: 11 residues within 4Å: Chain A: F.191, F.192, L.196, L.352, I.356, C.359, F.360, F.363, C.364 Ligands: OLA.8, OLC.27 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.191, A:F.192, A:L.196, A:L.352, A:I.356, A:F.360, A:F.360, A:F.360, A:F.363, A:F.363

21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)

OLA.6: 7 residues within 4Å: Chain A: V.66, T.74, T.77, F.79 Ligands: OLA.24, OLA.25, OLC.29 Ligand excluded by PLIP OLA.7: 5 residues within 4Å: Chain A: H.369, P.371, L.374, L.377 Ligands: CLR.4 Ligand excluded by PLIP OLA.8: 7 residues within 4Å: Chain A: L.199, L.203, F.210, A.341, G.345 Ligands: CLR.5, OLA.18 Ligand excluded by PLIP OLA.9: 5 residues within 4Å: Chain A: A.82, H.84, G.85 Ligands: CLR.3, OLA.20 Ligand excluded by PLIP OLA.10: 5 residues within 4Å: Chain A: L.28, T.384, V.387, V.388, F.391 Ligand excluded by PLIP OLA.11: 7 residues within 4Å: Chain A: G.14, S.15, V.17, V.21, L.372, Y.376, L.377 Ligand excluded by PLIP OLA.12: 4 residues within 4Å: Chain A: I.136, A.143 Ligands: OLA.16, OLA.19 Ligand excluded by PLIP OLA.13: 3 residues within 4Å: Chain A: L.28, G.32, F.391 Ligand excluded by PLIP OLA.14: 1 residues within 4Å: Chain A: W.373 Ligand excluded by PLIP OLA.15: 3 residues within 4Å: Chain A: S.16, T.20, L.23 Ligand excluded by PLIP OLA.16: 7 residues within 4Å: Chain A: R.129, G.132, I.136, V.139, L.140 Ligands: OLA.12, OLA.19 Ligand excluded by PLIP OLA.17: 5 residues within 4Å: Chain A: V.34, C.37, W.38, W.41 Ligands: OLC.31 Ligand excluded by PLIP OLA.18: 6 residues within 4Å: Chain A: A.341, I.342, G.345, L.349, L.352 Ligands: OLA.8 Ligand excluded by PLIP OLA.19: 9 residues within 4Å: Chain A: H.84, V.139, L.140, A.143, M.149, L.150 Ligands: OLA.12, OLA.16, OLA.20 Ligand excluded by PLIP OLA.20: 6 residues within 4Å: Chain A: H.84, F.142, M.149 Ligands: OLA.9, OLA.19, OLA.21 Ligand excluded by PLIP OLA.21: 7 residues within 4Å: Chain A: A.131, A.135, V.139, F.142 Ligands: OLA.20, OLA.23, OLC.30 Ligand excluded by PLIP OLA.22: 5 residues within 4Å: Chain A: A.106, I.109, V.125, I.133, C.137 Ligand excluded by PLIP OLA.23: 5 residues within 4Å: Chain A: T.128, A.131, G.132, A.135 Ligands: OLA.21 Ligand excluded by PLIP OLA.24: 2 residues within 4Å: Chain A: I.19 Ligands: OLA.6 Ligand excluded by PLIP OLA.25: 2 residues within 4Å: Ligands: OLA.6, OLC.29 Ligand excluded by PLIP OLA.26: 2 residues within 4Å: Chain A: I.392, Y.395 Ligand excluded by PLIP

5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.27: 4 residues within 4Å: Chain A: L.196, F.363 Ligands: CLR.5, OLC.28 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.196, A:F.363 OLC.28: 5 residues within 4Å: Chain A: Y.188, L.200, F.362, F.363 Ligands: OLC.27 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.200 Hydrogen bonds: A:F.362 OLC.29: 10 residues within 4Å: Chain A: L.67, P.70, F.71, T.74, F.79, C.80, Q.172 Ligands: CLR.3, OLA.6, OLA.25 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.67, A:P.70, A:F.71, A:T.74, A:F.79 Hydrogen bonds: A:Q.172, A:Q.172 OLC.30: 10 residues within 4Å: Chain A: Y.52, V.55, A.59, L.63, G.127, I.134, W.138, F.142 Ligands: OLA.21, OLC.31 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.52, A:V.55, A:A.59, A:L.63, A:I.134, A:I.134, A:W.138, A:W.138, A:F.142, A:F.142 OLC.31: 8 residues within 4Å: Chain A: C.37, W.41, Y.52, V.55, A.59, L.63 Ligands: OLA.17, OLC.30 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:W.41, A:A.59, A:L.63 Hydrogen bonds: A:Y.52, A:Y.52

1 x TAR: D(-)-TARTARIC ACID(Non-covalent)

TAR.32: 6 residues within 4Å: Chain A: G.151, W.152, N.153, N.154, P.182, N.184 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.153, A:N.184

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheng, R.K.Y. et al., Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure (2017)

Release Date

2017-07-26

Peptides

Adenosine receptor A2a,Soluble cytochrome b562,ADENOSINE RECEPTOR A2A SOLUBLE CYTOCHROME B562 ADENOSINE RECEPTOR A2A,Adenosine receptor A2a: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Adenosine receptor A2a,Soluble cytochrome b562,ADENOSINE RECEPTOR A2A SOLUBLE CYTOCHROME B562 ADENOSINE RECEPTOR A2A,Adenosine receptor A2a

Related Entries With Identical Sequence